On the basis of findings of observational studies and a meta-analysis, proteinuria reduction has been proposed as a surrogate outcome in IgA nephropathy. How long a reduction in proteinuria needs to be maintained to mitigate the long-term risk of disease progression is unknown.

Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy

Mariano F
Membro del Collaboration Group
2021-01-01

Abstract

On the basis of findings of observational studies and a meta-analysis, proteinuria reduction has been proposed as a surrogate outcome in IgA nephropathy. How long a reduction in proteinuria needs to be maintained to mitigate the long-term risk of disease progression is unknown.
2021
32
2
436
447
IgA nephropathy; end stage kidney disease; epidemiology and outcomes; glomerular disease; proteinuria; renal function decline; renal pathology
Canney, Mark; Barbour, Sean J; Zheng, Yuyan; Coppo, Rosanna; Zhang, Hong; Liu, Zhi-Hong; Matsuzaki, Keiichi; Suzuki, Yusuke; Katafuchi, Ritsuko; Reich, Heather N; Cattran, Daniel, International IgA Nephropathy Network; International IgA Nephropathy Network Investigators; Mariano F
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1770238
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
social impact